Quidel’s Stock Soars In Response To Avian Flu Threat, Gains 22.7% In October
This article was originally published in The Gray Sheet
Executive Summary
Anticipation of the flu season and the threat of a global pandemic fueled Wall Street's attention on influenza test manufacturer Quidel in October